Clinical Trial Update: Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating D-cycloserine targeting a genetic mutation in glycine metabolism for schizophrenia and bipolar disorder; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Mclean Hospital | Conditions: Schizophrenia, Bipolar Disorder | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2017-09-19